By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its first-quarter molecular diagnostics sales increased 6 percent year over year as its total sales were up around 5 percent compared to Q1 2011.

Abbott reported molecular diagnostics sales of $105 million, up from $99 million for the first quarter of 2011. Of that total, $47 million came from the US market and $58 million in sales were derived from international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.